Toxovax®
Toxovax is an injectable live vaccine used in susceptible breeding female sheep to stimulate active immunity against Toxoplasma gondii, a ubiquitous parasite acquired from the environment, and a common cause of barrenness and abortion.
Toxovax®eShop
Your online web-shop for ordering Toxovax®.
To register, please talk to your MSD Ruminant Account Manager.
Presentation
Concentrate and solvent for suspension for injection for sheep.
Concentrate: Cloudy suspension. Solvent (Unisolve): Colourless solution
Active ingredients
Live, concentrated vaccine containing ≥ 105 tachyzoites of the S48 strain of Toxoplasma gondii per dose. Unisolve is supplied as a solvent for reconstitution prior to use.
Target species
Sheep (ewes).
Indications for use
Toxovax is a live vaccine for the active immunisation of susceptible breeding female sheep to reduce the effects of infection by Toxoplasma gondii, namely early embryonic death, barrenness and abortion.
A single 2 ml, intramuscular injection is given at least 3 weeks prior to mating.
Vaccination with Toxovax is known to protect for at least two lambing seasons. Toxovax can be given concurrently with Enzovax®.
Withdrawal periods
Sheep - Meat and offal: 42 days.
Packaging
Pack sizes:
Cardboard box with 1 x vial of 20 doses of vaccine and 1 x vial of 40 ml of solvent and a transfer spike.
Cardboard box with 1 x vial of 50 doses of vaccine and 1 x vial of 100 ml of solvent and a transfer spike.
Cardboard box with 1 x vial of 20 doses of vaccine and a cardboard box with 1 x vial of 40 ml of solvent (add transfer spike if appropriate to either cardboard box).
Cardboard box with 1 x vial of 50 doses of vaccine and a cardboard box with 1 x vial of 100 ml of solvent (add transfer spike if appropriate to either cardboard box).
Not all pack sizes may be marketed.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: November 2025
Enzovax® contains live attenuated Chlamydia abortus. POM-V
Further information is available from the SPC, datasheet or package leaflet. Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.